2025 Q4 -tulosraportti
18 päivää sitten
‧18 min
0,50 SEK/osake
Viimeisin osinko
2,14%Tuotto/v
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
52
Myynti
Määrä
96
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 45 | - | - | ||
| 13 | - | - | ||
| 979 | - | - | ||
| 21 | - | - |
Ylin
71,4VWAP
Alin
67,4VaihtoMäärä
0,7 10 794
VWAP
Ylin
71,4Alin
67,4VaihtoMäärä
0,7 10 794
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.1. | ||
2025 Q3 -tulosraportti 28.10.2025 | ||
2025 Q2 -tulosraportti 18.7.2025 | ||
2025 Q1 -tulosraportti 29.4.2025 | ||
2024 Q4 -tulosraportti 28.1.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·27.1.Another good financial report. Today's volume was 9 times higher than the average daily volume (3 months). Still undervalued on many parameters.
·28.10.2025Good report, but what good is it when the stock is so infernally boring?
·27.1.Had them from 2007 to 2015 when they were sold between 38 - 40 kronor. The dividend over all years was approx. 58 thousand and the profit approx. 227 thousand. Unfortunately, the price rose to approx. 80 kronor a bit later, but still a good deal. There was some turbulence, if I recall correctly. The company issued a profit warning, after which a really good report was presented! Regards
·23.9.2025Yahoo finance sees upside for MSAB according to: "Micro Systemation (OM:MSAB B) Today's price: SEK 61.60 'Fair value' (Est.) : SEK 121.94 49.5%" https://finance.yahoo.com/news/3-european-stocks-possibly-trading-103805520.html
·7.7.2025Bought into MSAB The growth is not very exciting right now (+1.3%, basically zero adjusted for currency), but what made me push to buy is the profitability. EBIT has improved significantly (from -8.7 to -1.2 MSEK) and the gross margin remains at an incredible 93–94%, which says a lot about the strength of their software model. XRY Pro has quickly become a large part of sales (30% in two years), and now they are also starting to grow in APAC and EMEA. The US is slower right now due to changes in administration, but that is temporary. The strategy going forward feels clear – more innovation and focus on customer-oriented solutions. With a ROCE of over 50%, I see this as a case where profits can scale nicely if growth picks up again. Feels like a reasonable long-term holding at a low valuation.
·18.7.2025Have owned the stock for decades but realize that the company is not keeping up. Cellebrite. That stock has tripled in the last 2 years but MSAB is standing still. They needed a partner in the US but management hasn't figured it out. That's exactly what Cellebrite has.·21.7.2025Interesting comment :)Haha, you've really captured MSAB's challenges here! It feels like they're just standing there and stomping around in the US, while Cellebrite is pushing ahead with their partnership and rolling in money. But MSAB still has a really fat gross margin of 93–94%, which means they're doing something right - they're like a gold mine, they just have to find the right partner to dig it up with. If they can pull it off, and continue with their innovation focus, I think they can really speed things up. Their ROCE of over 50% is like they have a turbo in their engine, they just have to get the wheels turning faster!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
18 päivää sitten
‧18 min
0,50 SEK/osake
Viimeisin osinko
2,14%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·27.1.Another good financial report. Today's volume was 9 times higher than the average daily volume (3 months). Still undervalued on many parameters.
- ·28.10.2025Good report, but what good is it when the stock is so infernally boring?·27.1.Had them from 2007 to 2015 when they were sold between 38 - 40 kronor. The dividend over all years was approx. 58 thousand and the profit approx. 227 thousand. Unfortunately, the price rose to approx. 80 kronor a bit later, but still a good deal. There was some turbulence, if I recall correctly. The company issued a profit warning, after which a really good report was presented! Regards
- ·23.9.2025Yahoo finance sees upside for MSAB according to: "Micro Systemation (OM:MSAB B) Today's price: SEK 61.60 'Fair value' (Est.) : SEK 121.94 49.5%" https://finance.yahoo.com/news/3-european-stocks-possibly-trading-103805520.html
- ·7.7.2025Bought into MSAB The growth is not very exciting right now (+1.3%, basically zero adjusted for currency), but what made me push to buy is the profitability. EBIT has improved significantly (from -8.7 to -1.2 MSEK) and the gross margin remains at an incredible 93–94%, which says a lot about the strength of their software model. XRY Pro has quickly become a large part of sales (30% in two years), and now they are also starting to grow in APAC and EMEA. The US is slower right now due to changes in administration, but that is temporary. The strategy going forward feels clear – more innovation and focus on customer-oriented solutions. With a ROCE of over 50%, I see this as a case where profits can scale nicely if growth picks up again. Feels like a reasonable long-term holding at a low valuation.·18.7.2025Have owned the stock for decades but realize that the company is not keeping up. Cellebrite. That stock has tripled in the last 2 years but MSAB is standing still. They needed a partner in the US but management hasn't figured it out. That's exactly what Cellebrite has.·21.7.2025Interesting comment :)Haha, you've really captured MSAB's challenges here! It feels like they're just standing there and stomping around in the US, while Cellebrite is pushing ahead with their partnership and rolling in money. But MSAB still has a really fat gross margin of 93–94%, which means they're doing something right - they're like a gold mine, they just have to find the right partner to dig it up with. If they can pull it off, and continue with their innovation focus, I think they can really speed things up. Their ROCE of over 50% is like they have a turbo in their engine, they just have to get the wheels turning faster!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
52
Myynti
Määrä
96
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 45 | - | - | ||
| 13 | - | - | ||
| 979 | - | - | ||
| 21 | - | - |
Ylin
71,4VWAP
Alin
67,4VaihtoMäärä
0,7 10 794
VWAP
Ylin
71,4Alin
67,4VaihtoMäärä
0,7 10 794
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.1. | ||
2025 Q3 -tulosraportti 28.10.2025 | ||
2025 Q2 -tulosraportti 18.7.2025 | ||
2025 Q1 -tulosraportti 29.4.2025 | ||
2024 Q4 -tulosraportti 28.1.2025 |
2025 Q4 -tulosraportti
18 päivää sitten
‧18 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.4. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 27.1. | ||
2025 Q3 -tulosraportti 28.10.2025 | ||
2025 Q2 -tulosraportti 18.7.2025 | ||
2025 Q1 -tulosraportti 29.4.2025 | ||
2024 Q4 -tulosraportti 28.1.2025 |
0,50 SEK/osake
Viimeisin osinko
2,14%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·27.1.Another good financial report. Today's volume was 9 times higher than the average daily volume (3 months). Still undervalued on many parameters.
- ·28.10.2025Good report, but what good is it when the stock is so infernally boring?·27.1.Had them from 2007 to 2015 when they were sold between 38 - 40 kronor. The dividend over all years was approx. 58 thousand and the profit approx. 227 thousand. Unfortunately, the price rose to approx. 80 kronor a bit later, but still a good deal. There was some turbulence, if I recall correctly. The company issued a profit warning, after which a really good report was presented! Regards
- ·23.9.2025Yahoo finance sees upside for MSAB according to: "Micro Systemation (OM:MSAB B) Today's price: SEK 61.60 'Fair value' (Est.) : SEK 121.94 49.5%" https://finance.yahoo.com/news/3-european-stocks-possibly-trading-103805520.html
- ·7.7.2025Bought into MSAB The growth is not very exciting right now (+1.3%, basically zero adjusted for currency), but what made me push to buy is the profitability. EBIT has improved significantly (from -8.7 to -1.2 MSEK) and the gross margin remains at an incredible 93–94%, which says a lot about the strength of their software model. XRY Pro has quickly become a large part of sales (30% in two years), and now they are also starting to grow in APAC and EMEA. The US is slower right now due to changes in administration, but that is temporary. The strategy going forward feels clear – more innovation and focus on customer-oriented solutions. With a ROCE of over 50%, I see this as a case where profits can scale nicely if growth picks up again. Feels like a reasonable long-term holding at a low valuation.·18.7.2025Have owned the stock for decades but realize that the company is not keeping up. Cellebrite. That stock has tripled in the last 2 years but MSAB is standing still. They needed a partner in the US but management hasn't figured it out. That's exactly what Cellebrite has.·21.7.2025Interesting comment :)Haha, you've really captured MSAB's challenges here! It feels like they're just standing there and stomping around in the US, while Cellebrite is pushing ahead with their partnership and rolling in money. But MSAB still has a really fat gross margin of 93–94%, which means they're doing something right - they're like a gold mine, they just have to find the right partner to dig it up with. If they can pull it off, and continue with their innovation focus, I think they can really speed things up. Their ROCE of over 50% is like they have a turbo in their engine, they just have to get the wheels turning faster!
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Stockholm
Määrä
Osto
52
Myynti
Määrä
96
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 7 | - | - | ||
| 45 | - | - | ||
| 13 | - | - | ||
| 979 | - | - | ||
| 21 | - | - |
Ylin
71,4VWAP
Alin
67,4VaihtoMäärä
0,7 10 794
VWAP
Ylin
71,4Alin
67,4VaihtoMäärä
0,7 10 794
Välittäjätilasto
Dataa ei löytynyt